The vaccinated animals still had some virus in their noses but significantly less than unvaccinated animals did
CAMBRIDGE, MASSACHUSETTS - MAY 08: A view of Moderna headquarters on May 08, 2020 in Cambridge, Massachusetts. Moderna was given FDA approval to continue to phase 2 of Coronavirus (COVID-19) vaccine trials with 600 participants. Image: Maddie Meyer/Getty Images
©2019 New York Times News Service